Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Antiarrhythmic Agents I: Mechanisms of Action and Clinical Pharmacology
Dean T. Mason
, A. N. DeMaria
, E. A. Aterdam
, R. Zelis
, R. A. Massumi
Department of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
19
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antiarrhythmic Agents I: Mechanisms of Action and Clinical Pharmacology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mechanism of Action
100%
Clinical Pharmacology
100%
Propranolol
100%
Antiarrhythmic Agents
100%
Phenytoin
85%
Quinidine
71%
Procainamide
71%
Conduction Velocity
42%
Potassium
28%
Reentry
28%
Antiarrhythmic Drugs
28%
Bidirectional Block
28%
Supraventricular Arrhythmia
28%
Tachyarrhythmia
28%
Refractory Period
28%
Automaticity
28%
Pacemaker Activity
14%
Pharmacological Effects
14%
Ventricular Arrhythmia
14%
Expected Benefits
14%
Electrophysiological Properties
14%
Action Potential Duration
14%
Drug Combination
14%
Refractoriness
14%
Atrioventricular Node
14%
Atrioventricular Block
14%
Rhythm Abnormality
14%
Entry Mechanism
14%
Diphenylhydantoin
14%
Rational Selection
14%
Digitalis Toxicity
14%
Diastolic Depolarization
14%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Pharmacology
100%
Propranolol
100%
Antiarrhythmic Agent
100%
Phenytoin
100%
Quinidine
71%
Lidocaine
71%
Procainamide
71%
Bretylium
57%
Isotopes of Potassium
28%
Reentry Arrhythmia
28%
Adrenergic Receptor Blocking Agent
14%
Heart Ventricle Tachycardia
14%
Supraventricular Tachycardia
14%
Atrioventricular Block
14%
Cholinergic Receptor Blocking Agent
14%
Heart Supraventricular Arrhythmia
14%
Antiarrhythmic Drug
14%
Digoxin Toxicity
14%